|
Company
Roster
|
Total
Insiders : |
46 |
|
|
Total
Direct Shares :
|
12,500,073 |
|
Total
Indirect Shares :
|
164,382,673 |
|
%
Held by Insiders:
|
6.93% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Trailsmith Pamela A |
Chief Scientific Officer |
2007-05-17 |
6,940 |
|
0 |
Fbb2 Llc |
Director, 10% Owner |
2012-06-15 |
18,243 |
|
0 |
667, L.p. |
Director |
2013-05-17 |
3,868,576 |
|
0 |
Berger Franklin M |
Director |
2014-02-21 |
204,720 |
|
0 |
Fbb3 Llc |
Director, 10% Owner |
2014-12-09 |
12,678 |
|
0 |
Drachman Jonathan G |
CMO & EVP, R & D |
2018-03-20 |
201,973 |
|
0 |
Cline Darren S |
EVP, Commercial |
2018-11-29 |
72,556 |
|
0 |
Romp Charles R |
|
2023-12-14 |
0 |
|
0 |
Sing Amy |
Sr. Director Medical Affairs |
2003-08-18 |
52,107 |
2003-08-14 |
0 |
Senter Peter |
Vice President, Chemistry |
2003-08-21 |
68,148 |
2003-08-21 |
0 |
Fell H Perry |
Chairman, Director |
2003-12-02 |
1,294,000 |
2003-09-04 |
0 |
Hellstrom Karl Erik |
Director |
2003-11-19 |
700,000 |
2003-11-14 |
0 |
Carroll Tim |
CFO |
2005-05-05 |
62,861 |
2003-12-02 |
0 |
Dobmeier Eric |
Chief Operating Officer |
2017-12-04 |
119,860 |
2004-05-05 |
0 |
Powell Michael |
Director |
2004-12-16 |
20,001 |
2004-12-16 |
647,577 |
Gryska David W |
|
2023-12-14 |
0 |
2006-02-14 |
0 |
Delphi Bioinvestments Vi Lp |
10% Owner |
2007-01-17 |
1,980,200 |
2007-01-17 |
2,000,000 |
Gallen Jonathan |
10% Owner |
|
0 |
2007-02-06 |
5,132,750 |
Rosenberg Morris |
EVP, Process Sciences |
2012-06-12 |
17,643 |
2007-04-27 |
0 |
Simpson Todd E |
|
2023-12-14 |
0 |
2007-09-26 |
0 |
Jp Morgan Partners Bhca Lp |
10% Owner |
2007-12-10 |
2,236,980 |
2007-12-10 |
28,088 |
Lippman Marc E |
Director |
2021-05-14 |
53,740 |
2007-12-14 |
10,000 |
Reynolds Thomas C |
Chief Medical Officer |
2013-01-28 |
57,601 |
2008-09-22 |
0 |
Akkaraju Srinivas |
Director |
2020-05-15 |
41,503 |
2008-09-22 |
600,559 |
Hoth Daniel Floyd Jr |
Director |
2009-12-02 |
10,405 |
2009-12-02 |
0 |
Seeley Bruce J. |
EVP, Commerical |
2011-08-24 |
18,861 |
2011-08-19 |
0 |
Boerner Christopher S. |
Executive Vice President, Comm |
2014-08-26 |
72,358 |
2011-08-19 |
0 |
Mclaughlin John Peter |
Director |
2016-05-20 |
39,400 |
2011-09-09 |
0 |
Baker Bros Advisors Llc |
Director, 10% Owner |
2013-05-17 |
154,001 |
2013-05-17 |
326,648 |
Simonian Nancy A |
|
2023-12-14 |
0 |
2013-05-17 |
0 |
Orwin John A |
|
2023-12-14 |
0 |
2014-01-10 |
0 |
Liu Jean I |
|
2023-12-14 |
0 |
2014-12-01 |
0 |
14159, L.p. |
Director, 10% Owner |
2014-12-09 |
107,504 |
2014-12-10 |
24,995,342 |
Siegall Clay B |
President & CEO, Director |
2022-05-12 |
666,060 |
2016-09-10 |
0 |
Baker Felix |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Seth Alpna |
|
2023-12-14 |
0 |
2018-03-15 |
0 |
Dansey Roger D |
|
2023-12-14 |
0 |
2018-06-15 |
0 |
Taylor Robin G |
Chief Commercial Officer |
2019-12-19 |
33,025 |
2019-05-20 |
0 |
Love Ted W |
|
2023-12-14 |
0 |
2020-08-17 |
0 |
Baker Julian |
Director, 10% Owner |
2021-05-14 |
46,557 |
2021-05-14 |
43,309,073 |
Epstein David R |
|
2023-12-14 |
0 |
2022-11-09 |
0 |
Swain Sandra M |
|
2023-12-14 |
0 |
2022-11-09 |
0 |
Baker Bros. Advisors (gp) Llc |
Director, 10% Owner |
2023-05-31 |
46,557 |
2023-05-31 |
42,977,301 |
Welch Daniel G |
|
2023-12-14 |
0 |
2023-12-14 |
0 |
Baker Brothers Life Sciences Lp |
Former 10% Owner, Director |
2023-12-14 |
0 |
2023-12-14 |
0 |
Himes Vaughn B |
|
2023-12-14 |
0 |
2023-12-14 |
0 |
|